Convalescent plasma therapy for B-cell–depleted patients with protracted COVID-19

…, O Hermine, C Rouzaud, S Faguer… - Blood, The Journal …, 2020 - ashpublications.org
Anti-CD20 monoclonal antibodies are widely used for the treatment of hematological
malignancies or autoimmune disease but may be responsible for a secondary humoral deficiency. …

Effect of canakinumab vs placebo on survival without invasive mechanical ventilation in patients hospitalized with severe COVID-19: a randomized clinical trial

…, Y Chen, Y Li, S Whelan, S Noviello, S Faguer… - Jama, 2021 - jamanetwork.com
Importance Effective treatments for patients with severe COVID-19 are needed. Objective To
evaluate the efficacy of canakinumab, an anti–interleukin-1β antibody, in patients …

Spectrum of HNF1B mutations in a large cohort of patients who harbor renal diseases

…, B Knebelmann, AS Lebre, S Faguer… - Clinical Journal of the …, 2010 - journals.lww.com
Background and objectives: Hepatocyte nuclear factor 1β (HNF1β) is a transcription factor
that is critical for the development of kidney and pancreas. In humans, mutations in HNF1B …

Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised …

…, B Terrier, É Perrodeau, P Cohen, S Faguer… - Annals of the …, 2018 - ard.bmj.com
Objective To compare individually tailored, based on trimestrial biological parameter
monitoring, to fixed-schedule rituximab reinfusion for remission maintenance of antineutrophil …

Safety and immunogenicity of anti–SARS-CoV-2 messenger RNA vaccines in recipients of solid organ transplants

…, F Abravanel, C Couat, S Faguer… - Annals of internal …, 2021 - acpjournals.org
Background: Recipients of solid organ transplant (SOT) are a high-risk group for severe
SARS-CoV-2 infection. The mortality rate of patients with SOT during the COVID-19 pandemic …

Rituximab therapy for acute humoral rejection after kidney transplantation

S Faguer, N Kamar, C Guilbeaud-Frugier, M Fort… - …, 2007 - journals.lww.com
A pilot study was performed on eight consecutive renal-transplant (RT) patients presenting
with acute humoral rejection (AHR) to assess the efficacy of monoclonal anti-B cell antibodies…

[HTML][HTML] Diagnosis, management, and prognosis of HNF1B nephropathy in adulthood

S Faguer, S Decramer, N Chassaing… - Kidney international, 2011 - Elsevier
Mutations in HNF1B are responsible for a dominantly inherited disease with renal and
nonrenal consequences, including maturity-onset diabetes of the young (MODY) type 5. While …

High immunogenicity of a messenger RNA-based vaccine against SARS-CoV-2 in chronic dialysis patients

…, A Del Bello, O Marion, S Faguer… - Nephrology Dialysis …, 2021 - academic.oup.com
Background Patients with chronic kidney disease, dialysis patients and kidney transplant
patients are at high risk of developing severe coronavirus disease 2019 (COVID-19). Data …

[PDF][PDF] Truncating mutations in the adhesion G protein-coupled receptor G2 gene ADGRG2 cause an X-linked congenital bilateral absence of vas deferens

…, A Siegfried, V Mitchell, N Chassaing, S Faguer… - The American Journal of …, 2016 - cell.com
In 80% of infertile men with obstructive azoospermia caused by a congenital bilateral absence
of the vas deferens (CBAVD), mutations are identified in the cystic fibrosis transmembrane …

Characteristics and management of IgA vasculitis (Henoch‐Schönlein) in adults: data From 260 patients included in a french multicenter retrospective survey

…, B Lioger, M Catroux, S Faguer… - Arthritis & …, 2017 - Wiley Online Library
Objective Data on adult IgA vasculitis (Henoch‐Schönlein) (IgAV) are scarce. This survey
was designed to better define the clinical spectrum of IgAV and efficacy of treatments in a …